// company-profile

Beam Therapeutics Inc.

BEAM
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings121Insiders16
// api This Beam Therapeutics Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 10 insiders purchased shares (net $34K). Buying was led by Ciaramella Giuseppe.

// 90-day insight

Over the last 90 days, Beam Therapeutics Inc. insiders bought $34K across 16 transactions with no open-market sales.

  • Most active insider: Evans John M. with 8 transactions totaling $1.9M.
  • Largest single sale: $739K by Evans John M. on Apr 1, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Beam Therapeutics Inc. as of 2026-03-31

— stable
Total reported AUM
$2.38B
QoQ change
-2.2%
Reporting period
2026-03-31
#1
ARK Investment Management LLC
CIK 1697748
$289.1M
12.1M shares
#2
FARALLON CAPITAL MANAGEMENT LLC
CIK 909661
$241.5M
10.1M shares
#3
FMR LLC
CIK 315066
$149.6M
6.3M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 17, 2026Ciaramella GiuseppeBEAM
Option Exercise
6,505$0.00$0K
Jun 17, 2026Ciaramella GiuseppeBEAM
Option Exercise
6,505$0.67$4K
Jun 17, 2026Ciaramella GiuseppeBEAM
Option Exercise
29,000$0.00$0K
Jun 17, 2026Ciaramella GiuseppeBEAM
Option Exercise
29,000$1.03$30K
Jun 3, 2026Walsh Kathleen EBEAM
Award
19,676$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.